HUM-MOLGEN DIAGnostics/Clinical Research

1/8/96

12,4 translocation patient/reply to Eileen B

With regard to the 12,4 translocation patient, we have some experience with chr12 abnormalities. I would be happy to provide info to thi s patient, but would need more information regarding the details of the cytogenetic localization of the breakpoints, i.e. what giemsa band.

Craig T. Basson M.D, Ph.D.

Cardiovascular Genetics Center

Brigham and Women's Hospital

Boston, MA

Pager (617)732-6987, #4133

Email Basson@rascal.med.harvard.edu